IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fairmount Funds Management LLC

Q4 2020 Holdings

Filed 2021-02-12 | 18 holdings | $74.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$24.1M450,31732.4%
Axsome Therapeutics Inc(AXSM)COM05464T104$17.9M220,09824.1%
Cogent Biosciences Inc(COGT)COM19240Q201$17.5M1,558,97523.5%
Argenx SE(ARGX)SPONSORED ADR04016X101$14.7M49,95019.7%
Insmed Inc(INSM)COM PAR $.01457669307$32.0K961,7970.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$30.4K1,315,3950.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$26.3K565,8900.0%
Trillium Therapeutics IncCOM NEW89620X506$21.7K1,478,1810.0%
Allakos Inc(ALLKGUSD)COM01671P100$20.7K147,6620.0%
Zogenix IncCOM NEW98978L204$19.6K980,6450.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$13.3K60,5000.0%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$10.9K702,3510.0%
Global Blood Therapeutics inCOM37890U108$9.3K215,0000.0%
Amarin Corp PLCSPONS ADR NEW023111206$7.4K1,508,2370.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$6.3K150,4330.0%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$6.3K257,0160.0%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$700100,0000.0%
Miragen Therapeutics IncCOM NEW60463E202$55435,0920.0%